Global Pediatric Drugs and Vaccines Market Growth 2024-2030
The global Pediatric Drugs and Vaccines market, valued at US$ 93,410 million in 2023, will see growth as demand increases for treatments and vaccines specifically for children.
- Bonafide Trust
- 10-09-2024
- Pages : 129
- Figures : 86
- Tables : 177
- Region : Global
- Category : Lifescience & Healthcare
- Pharmaceutical
The global pediatric drugs and vaccines market is a rapidly growing sector within the healthcare industry, driven by the increasing need to address pediatric diseases and ensure child health and well-being. Pediatric drugs and vaccines are essential for the prevention, treatment, and management of various diseases in infants, children, and adolescents, including infectious diseases, cancer, allergies, respiratory conditions, nervous system disorders, cardiovascular diseases, and diabetes. The market is segmented by product (vaccines and drugs), disease indication, distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region. Technological advancements in drug formulation and delivery systems, increasing awareness among parents and caregivers about the importance of timely vaccinations, and government initiatives to promote pediatric healthcare are key drivers of market growth. Additionally, the rising pediatric population and the prevalence of chronic diseases in children are contributing to the demand for pediatric drugs and vaccines. The market is also benefiting from the expansion of pediatric clinical trials and the development of innovative treatments, ensuring better health outcomes for children worldwide. Key players in the market include Novartis AG, AstraZeneca, GlaxoSmithKline plc, Sanofi, Merck Sharp & Dohme Corp., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Bharat Biotech, Zydus Cadila, Serum Institute of India Pvt. Ltd., and Panacea Biotec Limited. The research report highlights the growth potential of the global Pediatric Drugs and Vaccines market. Pediatric Drugs and Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pediatric Drugs and Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pediatric Drugs and Vaccines market.
According to Publisher, the global Pediatric Drugs and Vaccines market size was valued at US$ 93410 million in 2023. With growing demand in downstream market, the Pediatric Drugs and Vaccines is forecast to a readjusted size of US$ 174930 million by 2030 with a CAGR of 9.4% during review period. The global pediatric drugs and vaccines market is driven by several key factors, including the rising pediatric population, increasing prevalence of pediatric diseases, technological advancements, and government initiatives. The growing number of births globally, particularly in emerging markets, is leading to a higher demand for pediatric healthcare products. Chronic diseases such as asthma, diabetes, and epilepsy are becoming more common in children, necessitating long-term therapeutic solutions. Technological advancements in drug formulation and delivery systems are enabling the development of more effective and child-friendly medications, such as chewable tablets and dissolvable strips. Additionally, increasing awareness among parents and caregivers about the importance of timely vaccinations and preventive healthcare measures is leading to higher immunization rates. Government initiatives and funding for pediatric healthcare programs are providing a significant boost to market growth, with many countries implementing vaccination campaigns to eradicate infectious diseases. The expanding scope of pediatric clinical trials, driven by regulatory incentives, is accelerating the introduction of new and innovative treatments. These market drivers collectively contribute to the robust expansion of the global pediatric drugs and vaccines market, ensuring better health outcomes for children worldwide. Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleThe global pediatric drugs and vaccines market is segmented by type into vaccines and drugs. The vaccines segment is further divided into monovalent and multivalent vaccines. Monovalent vaccines are designed to protect against a single pathogen, while multivalent vaccines target multiple pathogens in a single formulation. Monovalent vaccines are preferred for their safety and stability, and they are widely used in national immunization programs to prevent diseases such as measles, mumps, rubella, and polio. Multivalent vaccines, on the other hand, offer the advantage of providing broader protection with fewer injections, making them particularly useful in regions with limited healthcare resources. The drugs segment includes a wide range of medications used to treat pediatric conditions such as infectious diseases, cancer, allergies, respiratory conditions, nervous system disorders, cardiovascular diseases, and diabetes. These drugs are formulated specifically for children, taking into account their unique physiological characteristics and developmental needs. The development of pediatric drugs involves rigorous testing to ensure safety, efficacy, and appropriate dosing for different age groups. Both vaccines and drugs play a crucial role in maintaining child health and preventing the spread of diseases, contributing to the overall growth and innovation in the global pediatric drugs and vaccines market.
The global pediatric drugs and vaccines market is segmented by application into prophylactic products and therapeutic products. Prophylactic products include vaccines that are administered to prevent diseases in infants, children, and adolescents. These vaccines are crucial for protecting against infectious diseases such as measles, mumps, rubella, polio, and influenza. The development and distribution of pediatric vaccines are supported by extensive research, clinical trials, and government initiatives to ensure high immunization rates and public health safety. Therapeutic products encompass a wide range of medications used to treat pediatric conditions such as infectious diseases, cancer, allergies, respiratory conditions, nervous system disorders, cardiovascular diseases, and diabetes. These drugs are specifically formulated for children, taking into account their unique physiological characteristics and developmental needs. The therapeutic segment also includes medications for chronic conditions that require long-term management and treatment. Both prophylactic and therapeutic products play a vital role in maintaining child health and preventing the spread of diseases, contributing to the overall growth and innovation in the global pediatric drugs and vaccines market.
The regional analysis of the global pediatric drugs and vaccines market reveals distinct trends and growth patterns across different geographical areas, highlighting its critical role in supporting regional economic development. The Asia-Pacific region dominates the market, driven by rapid industrialization, urbanization, and significant investments in construction and infrastructure development. Countries like China and India are leading the way, with robust domestic demand and supportive government policies promoting the use of pediatric drugs and vaccines in various industries. The North American region also holds a substantial market share, supported by advanced construction practices, high consumer awareness about the benefits of pediatric healthcare, and favorable regulatory environments. The European region is characterized by stringent environmental regulations and a strong focus on sustainable building practices, with countries like Germany and Italy investing in eco-friendly material production and promoting green construction. The Middle East and Africa regions are emerging markets, with increasing investments in infrastructure and growing awareness about the advantages of pediatric drugs and vaccines. Each region presents unique opportunities and challenges, with regional players adapting to local market conditions and regulatory environments to drive growth and innovation in the global pediatric drugs and vaccines market.
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pediatric Drugs and Vaccines Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Pediatric Drugs and Vaccines by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Pediatric Drugs and Vaccines by Country/Region, 2019, 2023 & 2030
- 2.2 Pediatric Drugs and Vaccines Segment by Type
- 2.2.1 Diphtheria
- 2.2.2 Influenza
- 2.2.3 Hepatitis
- 2.2.4 Pneumococcal Diseases
- 2.2.5 Meningococcal Diseases
- 2.2.6 Mumps
- 2.2.7 Others
- 2.3 Pediatric Drugs and Vaccines Sales by Type
- 2.3.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2019-2024)
- 2.3.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Pediatric Drugs and Vaccines Sale Price by Type (2019-2024)
- 2.4 Pediatric Drugs and Vaccines Segment by Application
- 2.4.1 Newborn
- 2.4.2 Infant
- 2.4.3 Child
- 2.5 Pediatric Drugs and Vaccines Sales by Application
- 2.5.1 Global Pediatric Drugs and Vaccines Sale Market Share by Application (2019-2024)
- 2.5.2 Global Pediatric Drugs and Vaccines Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Pediatric Drugs and Vaccines Sale Price by Application (2019-2024)
- 3 Global Pediatric Drugs and Vaccines by Company
- 3.1 Global Pediatric Drugs and Vaccines Breakdown Data by Company
- 3.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Company (2019-2024)
- 3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Company (2019-2024)
- 3.2 Global Pediatric Drugs and Vaccines Annual Revenue by Company (2019-2024)
- 3.2.1 Global Pediatric Drugs and Vaccines Revenue by Company (2019-2024)
- 3.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2019-2024)
- 3.3 Global Pediatric Drugs and Vaccines Sale Price by Company
- 3.4 Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Pediatric Drugs and Vaccines Product Location Distribution
- 3.4.2 Players Pediatric Drugs and Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for Pediatric Drugs and Vaccines by Geographic Region
- 4.1 World Historic Pediatric Drugs and Vaccines Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Pediatric Drugs and Vaccines Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Pediatric Drugs and Vaccines Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Pediatric Drugs and Vaccines Market Size by Country/Region (2019-2024)
- 4.2.1 Global Pediatric Drugs and Vaccines Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Pediatric Drugs and Vaccines Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Pediatric Drugs and Vaccines Sales Growth
- 4.4 APAC Pediatric Drugs and Vaccines Sales Growth
- 4.5 Europe Pediatric Drugs and Vaccines Sales Growth
- 4.6 Middle East & Africa Pediatric Drugs and Vaccines Sales Growth
- 5 Americas
- 5.1 Americas Pediatric Drugs and Vaccines Sales by Country
- 5.1.1 Americas Pediatric Drugs and Vaccines Sales by Country (2019-2024)
- 5.1.2 Americas Pediatric Drugs and Vaccines Revenue by Country (2019-2024)
- 5.2 Americas Pediatric Drugs and Vaccines Sales by Type
- 5.3 Americas Pediatric Drugs and Vaccines Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Pediatric Drugs and Vaccines Sales by Region
- 6.1.1 APAC Pediatric Drugs and Vaccines Sales by Region (2019-2024)
- 6.1.2 APAC Pediatric Drugs and Vaccines Revenue by Region (2019-2024)
- 6.2 APAC Pediatric Drugs and Vaccines Sales by Type
- 6.3 APAC Pediatric Drugs and Vaccines Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Pediatric Drugs and Vaccines by Country
- 7.1.1 Europe Pediatric Drugs and Vaccines Sales by Country (2019-2024)
- 7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2019-2024)
- 7.2 Europe Pediatric Drugs and Vaccines Sales by Type
- 7.3 Europe Pediatric Drugs and Vaccines Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Pediatric Drugs and Vaccines by Country
- 8.1.1 Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Pediatric Drugs and Vaccines Sales by Type
- 8.3 Middle East & Africa Pediatric Drugs and Vaccines Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines
- 10.3 Manufacturing Process Analysis of Pediatric Drugs and Vaccines
- 10.4 Industry Chain Structure of Pediatric Drugs and Vaccines
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Pediatric Drugs and Vaccines Distributors
- 11.3 Pediatric Drugs and Vaccines Customer
- 12 World Forecast Review for Pediatric Drugs and Vaccines by Geographic Region
- 12.1 Global Pediatric Drugs and Vaccines Market Size Forecast by Region
- 12.1.1 Global Pediatric Drugs and Vaccines Forecast by Region (2025-2030)
- 12.1.2 Global Pediatric Drugs and Vaccines Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Pediatric Drugs and Vaccines Forecast by Type
- 12.7 Global Pediatric Drugs and Vaccines Forecast by Application
- 13 Key Players Analysis
- 13.1 Merck & Co., Inc. (USA)
- 13.1.1 Merck & Co., Inc. (USA) Company Information
- 13.1.2 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 Merck & Co., Inc. (USA) Main Business Overview
- 13.1.5 Merck & Co., Inc. (USA) Latest Developments
- 13.2 Abbott Laboratories (USA)
- 13.2.1 Abbott Laboratories (USA) Company Information
- 13.2.2 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 Abbott Laboratories (USA) Main Business Overview
- 13.2.5 Abbott Laboratories (USA) Latest Developments
- 13.3 Amgen, Inc. (USA)
- 13.3.1 Amgen, Inc. (USA) Company Information
- 13.3.2 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Amgen, Inc. (USA) Main Business Overview
- 13.3.5 Amgen, Inc. (USA) Latest Developments
- 13.4 Eli Lilly and Company (USA)
- 13.4.1 Eli Lilly and Company (USA) Company Information
- 13.4.2 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Eli Lilly and Company (USA) Main Business Overview
- 13.4.5 Eli Lilly and Company (USA) Latest Developments
- 13.5 F. Hoffmann-La Roche Ltd (Switzerland)
- 13.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Information
- 13.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Main Business Overview
- 13.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments
- 13.6 Genentech, Inc. (USA)
- 13.6.1 Genentech, Inc. (USA) Company Information
- 13.6.2 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 Genentech, Inc. (USA) Main Business Overview
- 13.6.5 Genentech, Inc. (USA) Latest Developments
- 13.7 GlaxoSmithKline plc. (UK)
- 13.7.1 GlaxoSmithKline plc. (UK) Company Information
- 13.7.2 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 GlaxoSmithKline plc. (UK) Main Business Overview
- 13.7.5 GlaxoSmithKline plc. (UK) Latest Developments
- 13.8 Janssen Biologics B.V. (USA)
- 13.8.1 Janssen Biologics B.V. (USA) Company Information
- 13.8.2 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 Janssen Biologics B.V. (USA) Main Business Overview
- 13.8.5 Janssen Biologics B.V. (USA) Latest Developments
- 13.9 Actelion Pharmaceuticals
- 13.9.1 Actelion Pharmaceuticals Company Information
- 13.9.2 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 Actelion Pharmaceuticals Main Business Overview
- 13.9.5 Actelion Pharmaceuticals Latest Developments
- 13.10 AstraZeneca Plc. (UK)
- 13.10.1 AstraZeneca Plc. (UK) Company Information
- 13.10.2 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 AstraZeneca Plc. (UK) Main Business Overview
- 13.10.5 AstraZeneca Plc. (UK) Latest Developments
- 13.11 Boehringer Ingelheim GmbH (Germany)
- 13.11.1 Boehringer Ingelheim GmbH (Germany) Company Information
- 13.11.2 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Boehringer Ingelheim GmbH (Germany) Main Business Overview
- 13.11.5 Boehringer Ingelheim GmbH (Germany) Latest Developments
- 13.12 Bristol-Myers Squibb Company (USA)
- 13.12.1 Bristol-Myers Squibb Company (USA) Company Information
- 13.12.2 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 Bristol-Myers Squibb Company (USA) Main Business Overview
- 13.12.5 Bristol-Myers Squibb Company (USA) Latest Developments
- 13.13 Allergan, Inc. (USA)
- 13.13.1 Allergan, Inc. (USA) Company Information
- 13.13.2 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.13.4 Allergan, Inc. (USA) Main Business Overview
- 13.13.5 Allergan, Inc. (USA) Latest Developments
- 13.14 Novartis AG (Switzerland)
- 13.14.1 Novartis AG (Switzerland) Company Information
- 13.14.2 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.14.4 Novartis AG (Switzerland) Main Business Overview
- 13.14.5 Novartis AG (Switzerland) Latest Developments
- 13.15 Novo Nordisk A/S (Denmark)
- 13.15.1 Novo Nordisk A/S (Denmark) Company Information
- 13.15.2 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.15.4 Novo Nordisk A/S (Denmark) Main Business Overview
- 13.15.5 Novo Nordisk A/S (Denmark) Latest Developments
- 13.16 Pfizer, Inc. (USA)
- 13.16.1 Pfizer, Inc. (USA) Company Information
- 13.16.2 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.16.4 Pfizer, Inc. (USA) Main Business Overview
- 13.16.5 Pfizer, Inc. (USA) Latest Developments
- 13.17 Sanofi S.A (France)
- 13.17.1 Sanofi S.A (France) Company Information
- 13.17.2 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.17.4 Sanofi S.A (France) Main Business Overview
- 13.17.5 Sanofi S.A (France) Latest Developments
- 13.18 Shionogi Inc. (USA)
- 13.18.1 Shionogi Inc. (USA) Company Information
- 13.18.2 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.18.4 Shionogi Inc. (USA) Main Business Overview
- 13.18.5 Shionogi Inc. (USA) Latest Developments
- 13.19 Takeda
- 13.19.1 Takeda Company Information
- 13.19.2 Takeda Pediatric Drugs and Vaccines Product Portfolios and Specifications
- 13.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.19.4 Takeda Main Business Overview
- 13.19.5 Takeda Latest Developments
- 14 Research Findings and Conclusion
Table 1. Pediatric Drugs and Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pediatric Drugs and Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Diphtheria
Table 4. Major Players of Influenza
Table 5. Major Players of Hepatitis
Table 6. Major Players of Pneumococcal Diseases
Table 7. Major Players of Meningococcal Diseases
Table 8. Major Players of Mumps
Table 9. Major Players of Others
Table 10. Global Pediatric Drugs and Vaccines Sales by Type (2019-2024) & (K Units)
Table 11. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2019-2024)
Table 12. Global Pediatric Drugs and Vaccines Revenue by Type (2019-2024) & ($ million)
Table 13. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2019-2024)
Table 14. Global Pediatric Drugs and Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 15. Global Pediatric Drugs and Vaccines Sales by Application (2019-2024) & (K Units)
Table 16. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2019-2024)
Table 17. Global Pediatric Drugs and Vaccines Revenue by Application (2019-2024)
Table 18. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2019-2024)
Table 19. Global Pediatric Drugs and Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 20. Global Pediatric Drugs and Vaccines Sales by Company (2019-2024) & (K Units)
Table 21. Global Pediatric Drugs and Vaccines Sales Market Share by Company (2019-2024)
Table 22. Global Pediatric Drugs and Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Pediatric Drugs and Vaccines Revenue Market Share by Company (2019-2024)
Table 24. Global Pediatric Drugs and Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 25. Key Manufacturers Pediatric Drugs and Vaccines Producing Area Distribution and Sales Area
Table 26. Players Pediatric Drugs and Vaccines Products Offered
Table 27. Pediatric Drugs and Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Pediatric Drugs and Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 31. Global Pediatric Drugs and Vaccines Sales Market Share Geographic Region (2019-2024)
Table 32. Global Pediatric Drugs and Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Pediatric Drugs and Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Pediatric Drugs and Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 35. Global Pediatric Drugs and Vaccines Sales Market Share by Country/Region (2019-2024)
Table 36. Global Pediatric Drugs and Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Pediatric Drugs and Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Pediatric Drugs and Vaccines Sales by Country (2019-2024) & (K Units)
Table 39. Americas Pediatric Drugs and Vaccines Sales Market Share by Country (2019-2024)
Table 40. Americas Pediatric Drugs and Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country (2019-2024)
Table 42. Americas Pediatric Drugs and Vaccines Sales by Type (2019-2024) & (K Units)
Table 43. Americas Pediatric Drugs and Vaccines Sales by Application (2019-2024) & (K Units)
Table 44. APAC Pediatric Drugs and Vaccines Sales by Region (2019-2024) & (K Units)
Table 45. APAC Pediatric Drugs and Vaccines Sales Market Share by Region (2019-2024)
Table 46. APAC Pediatric Drugs and Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Pediatric Drugs and Vaccines Revenue Market Share by Region (2019-2024)
Table 48. APAC Pediatric Drugs and Vaccines Sales by Type (2019-2024) & (K Units)
Table 49. APAC Pediatric Drugs and Vaccines Sales by Application (2019-2024) & (K Units)
Table 50. Europe Pediatric Drugs and Vaccines Sales by Country (2019-2024) & (K Units)
Table 51. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2019-2024)
Table 52. Europe Pediatric Drugs and Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2019-2024)
Table 54. Europe Pediatric Drugs and Vaccines Sales by Type (2019-2024) & (K Units)
Table 55. Europe Pediatric Drugs and Vaccines Sales by Application (2019-2024) & (K Units)
Table 56. Middle East & Africa Pediatric Drugs and Vaccines Sales by Country (2019-2024) & (K Units)
Table 57. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Pediatric Drugs and Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Pediatric Drugs and Vaccines Sales by Type (2019-2024) & (K Units)
Table 61. Middle East & Africa Pediatric Drugs and Vaccines Sales by Application (2019-2024) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Pediatric Drugs and Vaccines
Table 63. Key Market Challenges & Risks of Pediatric Drugs and Vaccines
Table 64. Key Industry Trends of Pediatric Drugs and Vaccines
Table 65. Pediatric Drugs and Vaccines Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Pediatric Drugs and Vaccines Distributors List
Table 68. Pediatric Drugs and Vaccines Customer List
Table 69. Global Pediatric Drugs and Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 70. Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Pediatric Drugs and Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 72. Americas Pediatric Drugs and Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Pediatric Drugs and Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 74. APAC Pediatric Drugs and Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Pediatric Drugs and Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 76. Europe Pediatric Drugs and Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Pediatric Drugs and Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 78. Middle East & Africa Pediatric Drugs and Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Pediatric Drugs and Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 80. Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Pediatric Drugs and Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 82. Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 83. Merck & Co., Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 85. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Merck & Co., Inc. (USA) Main Business
Table 87. Merck & Co., Inc. (USA) Latest Developments
Table 88. Abbott Laboratories (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 90. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Abbott Laboratories (USA) Main Business
Table 92. Abbott Laboratories (USA) Latest Developments
Table 93. Amgen, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 95. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Amgen, Inc. (USA) Main Business
Table 97. Amgen, Inc. (USA) Latest Developments
Table 98. Eli Lilly and Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 100. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Eli Lilly and Company (USA) Main Business
Table 102. Eli Lilly and Company (USA) Latest Developments
Table 103. F. Hoffmann-La Roche Ltd (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 105. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. F. Hoffmann-La Roche Ltd (Switzerland) Main Business
Table 107. F. Hoffmann-La Roche Ltd (Switzerland) Latest Developments
Table 108. Genentech, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 110. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Genentech, Inc. (USA) Main Business
Table 112. Genentech, Inc. (USA) Latest Developments
Table 113. GlaxoSmithKline plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 115. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. GlaxoSmithKline plc. (UK) Main Business
Table 117. GlaxoSmithKline plc. (UK) Latest Developments
Table 118. Janssen Biologics B.V. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 120. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Janssen Biologics B.V. (USA) Main Business
Table 122. Janssen Biologics B.V. (USA) Latest Developments
Table 123. Actelion Pharmaceuticals Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 125. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. Actelion Pharmaceuticals Main Business
Table 127. Actelion Pharmaceuticals Latest Developments
Table 128. AstraZeneca Plc. (UK) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 130. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. AstraZeneca Plc. (UK) Main Business
Table 132. AstraZeneca Plc. (UK) Latest Developments
Table 133. Boehringer Ingelheim GmbH (Germany) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 135. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. Boehringer Ingelheim GmbH (Germany) Main Business
Table 137. Boehringer Ingelheim GmbH (Germany) Latest Developments
Table 138. Bristol-Myers Squibb Company (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 139. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 140. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Bristol-Myers Squibb Company (USA) Main Business
Table 142. Bristol-Myers Squibb Company (USA) Latest Developments
Table 143. Allergan, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 144. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 145. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. Allergan, Inc. (USA) Main Business
Table 147. Allergan, Inc. (USA) Latest Developments
Table 148. Novartis AG (Switzerland) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 149. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 150. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 151. Novartis AG (Switzerland) Main Business
Table 152. Novartis AG (Switzerland) Latest Developments
Table 153. Novo Nordisk A/S (Denmark) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 154. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 155. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 156. Novo Nordisk A/S (Denmark) Main Business
Table 157. Novo Nordisk A/S (Denmark) Latest Developments
Table 158. Pfizer, Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 159. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 160. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 161. Pfizer, Inc. (USA) Main Business
Table 162. Pfizer, Inc. (USA) Latest Developments
Table 163. Sanofi S.A (France) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 164. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 165. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 166. Sanofi S.A (France) Main Business
Table 167. Sanofi S.A (France) Latest Developments
Table 168. Shionogi Inc. (USA) Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 169. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 170. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 171. Shionogi Inc. (USA) Main Business
Table 172. Shionogi Inc. (USA) Latest Developments
Table 173. Takeda Basic Information, Pediatric Drugs and Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 174. Takeda Pediatric Drugs and Vaccines Product Portfolios and Specifications
Table 175. Takeda Pediatric Drugs and Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 176. Takeda Main Business
Table 177. Takeda Latest Developments
List of
Figure 1. Picture of Pediatric Drugs and Vaccines
Figure 2. Pediatric Drugs and Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pediatric Drugs and Vaccines Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Pediatric Drugs and Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Pediatric Drugs and Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Diphtheria
Figure 10. Product Picture of Influenza
Figure 11. Product Picture of Hepatitis
Figure 12. Product Picture of Pneumococcal Diseases
Figure 13. Product Picture of Meningococcal Diseases
Figure 14. Product Picture of Mumps
Figure 15. Product Picture of Others
Figure 16. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2023
Figure 17. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2019-2024)
Figure 18. Pediatric Drugs and Vaccines Consumed in Newborn
Figure 19. Global Pediatric Drugs and Vaccines Market: Newborn (2019-2024) & (K Units)
Figure 20. Pediatric Drugs and Vaccines Consumed in Infant
Figure 21. Global Pediatric Drugs and Vaccines Market: Infant (2019-2024) & (K Units)
Figure 22. Pediatric Drugs and Vaccines Consumed in Child
Figure 23. Global Pediatric Drugs and Vaccines Market: Child (2019-2024) & (K Units)
Figure 24. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2023)
Figure 25. Global Pediatric Drugs and Vaccines Revenue Market Share by Application in 2023
Figure 26. Pediatric Drugs and Vaccines Sales Market by Company in 2023 (K Units)
Figure 27. Global Pediatric Drugs and Vaccines Sales Market Share by Company in 2023
Figure 28. Pediatric Drugs and Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 29. Global Pediatric Drugs and Vaccines Revenue Market Share by Company in 2023
Figure 30. Global Pediatric Drugs and Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Pediatric Drugs and Vaccines Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Pediatric Drugs and Vaccines Sales 2019-2024 (K Units)
Figure 33. Americas Pediatric Drugs and Vaccines Revenue 2019-2024 ($ Millions)
Figure 34. APAC Pediatric Drugs and Vaccines Sales 2019-2024 (K Units)
Figure 35. APAC Pediatric Drugs and Vaccines Revenue 2019-2024 ($ Millions)
Figure 36. Europe Pediatric Drugs and Vaccines Sales 2019-2024 (K Units)
Figure 37. Europe Pediatric Drugs and Vaccines Revenue 2019-2024 ($ Millions)
Figure 38. Middle East & Africa Pediatric Drugs and Vaccines Sales 2019-2024 (K Units)
Figure 39. Middle East & Africa Pediatric Drugs and Vaccines Revenue 2019-2024 ($ Millions)
Figure 40. Americas Pediatric Drugs and Vaccines Sales Market Share by Country in 2023
Figure 41. Americas Pediatric Drugs and Vaccines Revenue Market Share by Country in 2023
Figure 42. Americas Pediatric Drugs and Vaccines Sales Market Share by Type (2019-2024)
Figure 43. Americas Pediatric Drugs and Vaccines Sales Market Share by Application (2019-2024)
Figure 44. United States Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 45. Canada Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 46. Mexico Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 47. Brazil Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 48. APAC Pediatric Drugs and Vaccines Sales Market Share by Region in 2023
Figure 49. APAC Pediatric Drugs and Vaccines Revenue Market Share by Regions in 2023
Figure 50. APAC Pediatric Drugs and Vaccines Sales Market Share by Type (2019-2024)
Figure 51. APAC Pediatric Drugs and Vaccines Sales Market Share by Application (2019-2024)
Figure 52. China Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. Japan Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. South Korea Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. Southeast Asia Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 56. India Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 57. Australia Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 58. China Taiwan Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 59. Europe Pediatric Drugs and Vaccines Sales Market Share by Country in 2023
Figure 60. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country in 2023
Figure 61. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2019-2024)
Figure 62. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2019-2024)
Figure 63. Germany Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. France Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 65. UK Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 66. Italy Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 67. Russia Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 68. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Country in 2023
Figure 69. Middle East & Africa Pediatric Drugs and Vaccines Revenue Market Share by Country in 2023
Figure 70. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2019-2024)
Figure 71. Middle East & Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2019-2024)
Figure 72. Egypt Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. South Africa Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 74. Israel Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 75. Turkey Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 76. GCC Country Pediatric Drugs and Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Pediatric Drugs and Vaccines in 2023
Figure 78. Manufacturing Process Analysis of Pediatric Drugs and Vaccines
Figure 79. Industry Chain Structure of Pediatric Drugs and Vaccines
Figure 80. Channels of Distribution
Figure 81. Global Pediatric Drugs and Vaccines Sales Market Forecast by Region (2025-2030)
Figure 82. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 83. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 84. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 85. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 86. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Application (2025-2030)
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (09 May, 2026)
- Notify To Team (09 May, 2026)
- Report updation (10 May, 2026)
- Report Quality Check (10 May, 2026)
- Report Dispatch (11 May, 2026)
- Hard Copy
Recently Viewed Products
Global Pediatric Drugs and Vaccines Market Growth 2024-2030
We are friendly and approachable, give us a call.